Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.
This is precisely where StockStory comes in - we do the heavy lifting to identify companies with solid fundamentals so you can invest with confidence. Keeping that in mind, here are two mid-cap stocks with long growth runways and one best left ignored.
One Mid-Cap Stock to Sell:
Clorox (CLX)
Market Cap: $9.89 billion
Founded in 1913 with bleach as the sole product offering, Clorox (NYSE: CLX) today is a consumer products giant whose product portfolio spans everything from bleach to skincare to salad dressing to kitty litter.
Why Does CLX Give Us Pause?
- Products aren’t resonating with the market as its revenue declined by 3.1% annually over the last three years
- Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
- Capital intensity has ramped up over the last year as its free cash flow margin decreased by 4.7 percentage points
At $82.18 per share, Clorox trades at 14.5x forward P/E. If you’re considering CLX for your portfolio, see our FREE research report to learn more.
Two Mid-Cap Stocks to Watch:
Crane (CR)
Market Cap: $11.82 billion
Based in Connecticut, Crane (NYSE: CR) is a diversified manufacturer of engineered industrial products, including fluid handling, and aerospace technologies.
Why Is CR on Our Radar?
- Efficiency rose over the last five years as its Operating margin increased by 5.3 percentage points
- Performance over the past two years shows its incremental sales were extremely profitable, as its annual earnings per share growth of 21.9% outpaced its revenue gains
- Free cash flow margin jumped by 5.4 percentage points over the last five years, giving the company more resources to pursue growth initiatives, repurchase shares, or pay dividends
Crane’s stock price of $204.61 implies a valuation ratio of 27.6x forward P/E. Is now a good time to buy? See for yourself in our full research report, it’s free.
UMB Financial (UMBF)
Market Cap: $10.25 billion
With roots dating back to 1913 and a name derived from "United Missouri Bank," UMB Financial (NASDAQ: UMBF) is a financial holding company that provides banking, asset management, and fund services to commercial, institutional, and individual customers.
Why Could UMBF Be a Winner?
- Annual revenue growth of 38.1% over the past two years was outstanding, reflecting market share gains this cycle
- Impressive 21.7% annual net interest income growth over the last five years indicates it’s winning market share this cycle
- Net interest margin expanded by 78.4 basis points (100 basis points = 1 percentage point) over the last two years, providing additional flexibility for investments
UMB Financial is trading at $134.69 per share, or 1.2x forward P/B. Is now the time to initiate a position? Find out in our full research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
